QGEN
QIAGEN N.V.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 6-K | 8/7/2026 | View on SEC |
| 6-K | 8/7/2026 | View on SEC |
| 6-K | 8/7/2026 | View on SEC |
| SCHEDULE 13G/A | 6/5/2026 | View on SEC |
| SD | 6/1/2026 | View on SEC |
| 6-K | 5/8/2026 | View on SEC |
| 6-K | 5/8/2026 | View on SEC |
| 6-K | 5/1/2026 | View on SEC |
| IRANNOTICE | 3/20/2026 | View on SEC |
| 20-F | 3/20/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | QGEN |
| Company Name | QIAGEN N.V. |
| CIK | 1015820 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | P7 |
| Phone | 31-77-35566-00 |